How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/intradermal-bcg-ssi-inj.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Intradermal BCG SSI inj. — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intradermal BCG SSI inj. (Intradermal BCG SSI inj.) competitive landscape: 1 comparator, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Live attenuated vaccine / Immunostimulant. Area: Oncology / Immunology.

phase 3 Live attenuated vaccine / Immunostimulant Oncology / Immunology Biologic Live · refreshed every 30 min

Target snapshot

Intradermal BCG SSI inj. (Intradermal BCG SSI inj.) — Green Cross Corporation. Intradermal BCG (Bacillus Calmette-Guérin) stimulates the immune system by activating innate and adaptive immunity to enhance anti-tumor or anti-infectious responses.

Comparator set (1 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
Intradermal BCG SSI inj. TARGET	Intradermal BCG SSI inj.	Green Cross Corporation	phase 3	Live attenuated vaccine / Immunostimulant
BCG for Therapeutic Use	BCG for Therapeutic Use	Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.	phase 3	Live attenuated vaccine / Immunostimulant	Pattern recognition receptors (TLRs); non-specific immune activation

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Live attenuated vaccine / Immunostimulant class)

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. · 1 drug in this class
Green Cross Corporation · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Intradermal BCG SSI inj. — Competitive Intelligence Brief. https://druglandscape.com/ci/intradermal-bcg-ssi-inj. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab